Clinical Trial Update: Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia

View source ↗

Summary

This clinical trial investigates how resistance to azacitidine-based therapies emerges in acute myeloid leukemia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Vidaza (azacitidine) (azacitidine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Myeloid Leukemia | Status: RECRUITING